指南与共识腹部胸部骨肌CT

基于人群的评估:美国国家综合癌症网络指南对肝细胞癌基线影像检查的推荐

Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
指南 / 共识 · Med Oncol · 2019-02-01

基于SEER数据库(2010-2015年)27,201例肝细胞癌患者,评估不同基线影像检查策略对肺和骨转移检测的性能。按现行推荐对所有新诊断病例行胸部横断面成像,肺转移PPV为5.0%、NNI为20.0;排除T1N0患者后肺转移PPV为6.8%、NNI为14.7,骨转移PPV为4.6%、NNI为21.7;排除T1N0且AFP正常患者后肺转移PPV为5.6%、NNI为17.8,骨转移PPV为3.8%、NNI为26.3。作者提示对无症状早期肝细胞癌且AFP正常的特定患者,可考虑省略常规基线胸部成像。

要点

  • 现行推荐对所有新诊断肝细胞癌行胸部横断面成像,肺转移PPV仅5.0%、NNI为20.0。
  • 排除T1N0患者后,肺转移PPV升至6.8%、NNI降至14.7,骨转移PPV为4.6%。
  • 作者认为对无症状早期且AFP正常的肝细胞癌患者,可考虑省略常规基线胸部成像。

核心结论

  • 现行推荐对所有新诊断肝细胞癌行胸部横断面成像时,肺转移检测PPV为5.0%、NNI为20.0。
  • 排除T1N0患者后,肺转移检测PPV为6.8%、NNI为14.7,骨转移检测PPV为4.6%、NNI为21.7。
  • 排除T1N0且AFP正常患者后,肺转移检测PPV为5.6%、NNI为17.8,骨转移检测PPV为3.8%、NNI为26.3。
  • 作者认为对无症状早期肝细胞癌且AFP正常的特定患者,可考虑省略常规基线胸部成像。

研究设计与样本

  • 基于SEER数据库(2010-2015年)的队列分析,纳入临床T分期、N分期及转移部位信息完整的肝细胞癌患者共27,201例。
  • 评估基线影像检查的多种性能特征,包括特异度、敏感度、阳性似然比、阴性似然比、需检查人数(NNI)、阴性预测值、阳性预测值和准确率。

诊断标准与关键数值

  • 现行推荐所有新诊断肝细胞癌行胸部横断面成像时,肺转移检测PPV为5.0%、NNI为20.0。
  • 排除T1N0患者后,肺转移检测PPV为6.8%、NNI为14.7,骨转移检测PPV为4.6%、NNI为21.7。
  • 排除T1N0且AFP正常患者后,肺转移检测PPV为5.6%、NNI为17.8,骨转移检测PPV为3.8%、NNI为26.3。

临床应用与阅片要点

  • 作者认为对无症状早期肝细胞癌且AFP正常的特定患者,可考虑省略常规基线胸部成像。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This analysis aims to evaluate the performance characteristics of alternative baseline imaging thresholds in a cohort of hepatocellular carcinoma (HCC) patients from the Surveillance, Epidemiology, and End Results (SEER) database. HCC patients within the SEER database (2010-2015) who had complete information on clinical T and N stages as well as complete information on metastatic sites were eligible for the current study. Various performance characteristics associated with baseline imaging were investigated, including specificity, sensitivity, positive likelihood ratio (LR), negative LR, number needed to investigate (NNI), negative predictive value (NPV), positive predictive value (PPV), and accuracy. A total of 27,201 HCC patients were included. Based on current recommendations that advocate for the use of cross-sectional chest imaging in all newly diagnosed cases of HCC, these recommendations would yield a PPV of 5.0% for the detection of lung metastases. This would translate to an NNI of 20.0. When T1N0 patients were excluded from routine chest or bone imaging, this resulted in a PPV of 6.8% for the identification of lung metastases and an NNI of 14.7. Likewise, this translated to a PPV of 4.6% for the identification of bone metastases and an NNI of 21.7. Similarly, when patients with T1N0 disease and normal alpha-fetoprotein (AFP) were excluded from routine imaging, this resulted in a PPV of 5.6% for the identification of lung metastases and an NNI of 17.8. Also, this translated to a PPV of 3.8% for the identification of bone metastases and an NNI of 26.3. The current study suggests that the omission of routine baseline chest imaging may be considered in selected patients with asymptomatic early-stage HCC and normal AFP.

来源:Med Oncol,查看原文。版权归原作者所有。

引用

  1. Abdel-Rahman O, Cheung WY. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma. Med Oncol. 2019. PMID: 30707324. doi:10.1007/s12032-019-1248-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。